Financings in Brief: Spectral Diagnostics
This article was originally published in The Gray Sheet
Spectral Diagnostics: Cardiac diagnostics company completes the sale of 750,000 special warrants for $8.90 (Canadian) each. The warrants each entitle holders to "acquire one common share of Spectral for no additional consideration," the company says. First Marathon Securities served as placement agent for the offering...
You may also be interested in...
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.